Do Fainter Lines on Home COVID Tests Mean You’re Getting Better?

Scientific American

The colors of lines on COVID tests can show whether you’re getting healthy or staying sick—if they’re interpreted the right way. It's important to remember that these assays were not developed to be quantitative, meaning they can’t officially tell you how much virus is in the sample.

Paul Drain, associate professor of global health and of epidemiology, is quoted.

Do Rapid Tests Still Work?

The New York Times

Experts say that rapid home tests are still a helpful tool for stopping the spread of COVID-19, but they’re not foolproof. Here are a few explanations for why you might get a false negative result — and how to increase your chances of accuracy next time.

Dr. Paul Drain, associate professor of global health and of medicine in the UW School of Medicine, is quoted.

Why Rapid COVID-19 Test Results Are Getting More Confusing

Time

Experts say ambiguous results on at-home tests may be more common now — but not because rapid tests aren’t working. In fact, these confusing results could actually be a good thing, at least as far as your immune system goes.

Dr. Paul Drain, associate professor of global health and of medicine in the UW School of Medicine, is quoted.

Paul Drain Appointed to NIH Study Section for Implementation Science

The National Institutes of Health recently announced new members to serve on the Science of Implementation in Health and Healthcare (SIHH) Study Section, including Paul Drain, Associate Professor at the University of Washington. Drain will serve a four-year term beginning in July 2021.

To be considered for a study section, candidates must be recognized authorities in their field and approved by the Director of the NIH.

STREAM Study Shows Point-of-Care Viral Load Testing Can Improve HIV Outcomes

The Simplifying HIV TREAtment and Monitoring (STREAM) study, led by Global Health professor Paul Drain and recently published in The Lancet HIV, found that point-of-care HIV viral load monitoring and task shifting significantly improved viral suppression and retention in HIV care, as compared to standard laboratory-based HIV viral load testing. This study was the first randomized controlled trial to compare rapid point-of-care HIV viral load testing against standard of care lab-based HIV viral load testing, which usually takes several weeks to return results to patients.

Global Health Professor Receives Grant to Develop Antigen-Based COVID-19 Test

With a new $765,120 grant, Global Health professor Paul Drain will lead a study to develop an antigen-based COVID-19 test – as well as evaluate PCR-based tests and immunological assays – to be used at the point of care. This grant, sponsored by the Bill and Melinda Gates Foundation, is titled “Developing and Evaluating Point-of-Care Antigen and Immunoassays for COVID-19 and Cytokine Release Syndrome among people being screened for SARS-CoV-2 infection in Seattle”.

New Research Aimed at Promoting Better Patient Adherence to HIV Medications

Paul Drain—an Associate Professor in the Department of Global Health, Medicine and Epidemiology at the University of Washington—and his research team have received a new grant from the CoMotion Innovation Gap Fund, a program intended to help bridge the gap between academic research grants and the level of development needed to obtain investment. Drain’s project is titled “Rapid test for measuring adherence to antiretroviral therapy and pre-exposure prophylaxis”.  

Point-of-Care HIV Viral Load Testing Combined with Task Shifting to Improve Treatment Outcomes (The Lancet - Includes Paul Drain, Ruanne Barnabas, and Connie Celum)

Point-of-care HIV viral load testing combined with task shifting can improve viral suppression and retention in care by up to 14% and enable rapid care decisions, suggest results of a clinical trial led by the University of Washington and the Centre for the AIDS Programme of Research in South Africa (CAPRISA).

New Project Aims to Optimize HIV Treatment in South Africa

Over half of the 37 million people worldwide living with HIV are receiving antiretroviral therapy (ART), yet only half of those people have suppressed replication of HIV with appropriate ART. A new project led by Dr. Paul Drain, an Associate Professor in the Departments of Global Health and Medicine at the University of Washington, aims to provide insight into the acceptability, feasibility, and impact of scaling-up the delivery of ART among adolescents and young adults living with HIV in community-based settings. Dr.

Pages